The strong financial case for regenerative medicine and the regen industry.

The strong financial case for regenerative medicine and the regen industry.

Item
http://www.wikidata.org/entity/Q34011549
Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver constructionStepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South KoreaQuantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors.Nanotechnology in the Regeneration of Complex Tissues.Opening the gateways to market and adoption of regenerative medicine? The UK case in context.Polymeric implant materials for the reconstruction of tracheal and pharyngeal mucosal defects in head and neck surgery.Challenges in the clinical application of induced pluripotent stem cells.Transforming healthcare through regenerative medicine.Financing cures in the United States.The need for a regen industry voice.Early evaluation and value-based pricing of regenerative medicine technologies.Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury
P2860

The strong financial case for regenerative medicine and the regen industry.

Item
http://www.wikidata.org/entity/Q34011549
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The strong financial case for regenerative medicine and the regen industry.
@ast
The strong financial case for regenerative medicine and the regen industry.
@en
The strong financial case for regenerative medicine and the regen industry.
@nl
type
label
The strong financial case for regenerative medicine and the regen industry.
@ast
The strong financial case for regenerative medicine and the regen industry.
@en
The strong financial case for regenerative medicine and the regen industry.
@nl
prefLabel
The strong financial case for regenerative medicine and the regen industry.
@ast
The strong financial case for regenerative medicine and the regen industry.
@en
The strong financial case for regenerative medicine and the regen industry.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
The strong financial case for regenerative medicine and the regen industry.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698